ARTICLES BY THIS AUTHOR
- 7/28/2021
FDA clears interchangeable insulin biosimilar Semglee
Semglee is both biosimilar to and interchangeable with Lantus, and is the first interchangeable biosimilar approved by the Food and Drug Administration. - 7/28/2021
Lannett inks distribution agreement for generic Spiriva Handihaler
Spiriva Handihaler had a market value of $1.5 billion for the 12 months ended May 2021, although actual generic market values are expected to be lower. - 7/27/2021
AAM taps Joanne Duncan as COO
Duncan will be responsible for leading and managing implementation of a more comprehensive member recruitment strategy at AAM. - 7/27/2021
Schnucks Fresh store debuts in Indiana
The store will include a heavy focus on fresh departments, such as produce, meat, seafood, deli and bakery items, the company said. - 7/27/2021
Business Group on Health: U.S. pharmaceutical supply chain needs overhaul
The Pharmaceutical Supply Chain Leadership Forum has made 70 specific reform recommendations, many of which address the need for increased transparency in therapeutic alternatives and actual out-of-pocket costs. - 7/27/2021
Merck obtains FDA OK for new indication of Keytruda
Keytruda is now approved for 30 indications. - 7/26/2021
FDA approves new Shingrix indication
Shingrix is now approved for the prevention of shingles in those who are immunocompromised. - 7/26/2021
Rolling with the punches: Generics firms innovate, expand scope to stay competitive
As they continue to navigate pandemic headwinds, generics firms look to broaden their portfolios and vertically integrate to keep competitive. - 7/26/2021
GSK starts shipping influenza vaccines for 2021-2022 season
GSK said it expects to distribute a record supply of more than 50 million doses of its influenza vaccine for the upcoming flu season.